Among the initiatives being suggested to find a solution to the COVID-19 pandemic is one originating from the Fonds de recherche du Québec and Génome Québec: they have mandated a group of researchers to create the Quebec COVID Biobank.

NewsGuest UserMarch 30, 2020Biobank, COVID19

Message sent to Minister Fitzgibbon's office regarding federal government programs that allow salaries to be subsidized up to 75%

Here is a copy of the message sent by Anie Perrault, BIOQuébec’s Executive Director, to Minister Fitzgibbon's office on March 30. It was also sent to our colleagues at BIOTECanada, who are in contact with the federal government. More than ever, BIOQuébec has the interests of its members at heart!

NewsGuest UserMarch 30, 2020Quebec Government, fitzgibbon

Coronavirus tracked: the latest figures as the pandemic spreads

The humanitarian costs of the coronavirus outbreak continue to mount, with more than 845,000 people infected globally. The number of people confirmed to have died having the virus has now surpassed 41,500.

NewsGuest UserMarch 24, 2020COVID19, Coronavirus, Curve, Finances

Canadian JAMP Pharma Group Gets Involved - Donating one million doses of hydroxychloroquine to hospitals to help combat COVID-19

JAMP Pharma Group, a Canadian pharmaceutical company, announced today that it is donating one million doses of hydroxychloroquine to Canadian hospitals, a drug that is normally used to treat malaria and rheumatoid arthritis and which could potentially be useful in treating hospitalized patients infected with the COVID-19 virus.

NewsGuest UserMarch 23, 2020COVID19, Coronavirus, JAMP Pharma Group, JAMP Pharma, Pharma

IMV Inc. Launches Plans to Advance Clinical Development of a Vaccine Candidate Against COVID-19

IMV Inc. announced that it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19. Vaccines against infectious disease have been a core part of IMV’s heritage across its DPX platform technology.

NewsGuest UserMarch 18, 2020COVID19, Coronavirus, IMV Inc., vaccine

Canada and the United Kingdom collaborate on responsible artificial intelligence

Canada is a global leader in artificial intelligence (AI)—the single-largest transformative technology in the world. Fostering Canada’s advantage in digital technologies, including AI, is one of the pillars of the Government of Canada’s economic growth strategy.

NewsGuest UserMarch 12, 2020artificial intelligence, AI, Government of Canada

QUEBEC BUDGET FOR 2020-2021: THE LIFE SCIENCES INDUSTRY: A KEY GOVERNMENT ALLY IN ATTRACTING INVESTMENTS, DEVELOPING QUEBEC’S ECONOMY, AND IMPROVING CITIZENS’ QUALITY OF LIFE

BIOQuébec welcomes the Quebec government’s newly tabled, balanced budget for 2020-2021, which acknowledges the biotechnology and life sciences sector’s economic role.

NewsGuest UserMarch 11, 2020BIOQuebec, budget, Quebec Government

New Board of Directors Appointments for Immune Biosolutions

Immune Biosolutions, an early-stage biopharmaceutical company focusing on the discovery, engineering and development of therapeutic humanized chicken antibodies, today announced the appointments of Drs. Nadine Beauger and Louise Proulx to its Board of Directors.

NewsGuest UserJanuary 22, 2020chicken antibodies, Board of directors, Immune Biosolutions

ExCellThera announces clinical data to be presented at the American Society of Hematology 2019 annual meeting

ExCellThera Inc., an advanced biotechnology company delivering molecules and bioengineering solutions to expand stem and immune cells for therapeutic use, announced today that data from a Phase I/II clinical trial using its lead technology, ECT-001, will be presented at the 61st Annual Meeting of the American Society of Hematology (ASH) in Orlando, Florida.

NewsGuest UserDecember 5, 2019ExCellThera, Hematology, ECT-001

Laurent Pharmaceuticals Receives a CAD 2.7M Financing from BioMed Propulsion Fund

Laurent Pharmaceuticals Inc. (the “Company”), a biopharmaceutical company focusing on rare diseases, today announced that it has received the final approval for a CAD 2.7M loan from the Quebec Government through its BioMed Propulsion program. This financing will help support the Company’s Phase 2 clinical study evaluating LAU-7b in adult patients with cystic fibrosis (“CF”).

Antech Diagnostics acquires leading Canadian animal reference laboratory, Biovet

Today, Antech Diagnostics, part of Mars Petcare, announced its acquisition of Saint Hyacinthe, Quebec-based Biovet, a biotechnology company providing unique expertise in the field of diagnostics for animal health and agro-industry specialists in Canada and internationally.

NewsGuest UserNovember 6, 2019Antech Diagnostics, Biovet, acquisition, animal health, agro-industry

PMPRB Changes will negatively impact Canada’s healthcare system and global competitiveness

The recent release of the Patented Medicine Prices Review Board’s modernized regulatory framework will negatively impact Canada’s competitiveness in attracting investment to commercialize Canadian innovation.

NewsGuest UserAugust 16, 2019BIOTECanada, Governement of Canada, Federal government, PMPRB

The Coolest Hotspot: Quebec's Life Sciences and Health Technologies Ecosystem Joins Promotion Forces Abroad

Following the diagnosis conducted by the life sciences sector working group mandated by the Quebec government, industry partners, local economic development and investment promotion agencies, as well as research organizations come together to promote the Quebec life sciences and health technologies (LSHT) ecosystem internationally. This network is proud to announce its new image: The Coolest Hotspot.

NewsGuest UserJune 3, 2019BIOQuebec, partnership, The Coolest Hotspot, Ça se passe ici

CDRD and NEOMED Institute Join Forces to Create a New Pan-Canadian Enterprise adMare BioInnovations

Two successful Canadian innovation organizations, CDRD, Canada’s national life sciences venture, and NEOMED Institute, a leading not-for-profit R&D organization building an innovation ecosystem in Montréal, are pleased to announce that effective today, they are bringing their respective capabilities and resources together under a new co-founded pan-Canadian enterprise, adMare BioInnovations.

NewsGuest UserMay 30, 2019BIOOQuébecCDRD, NÉOMED, adMare BioInnovations

Are you Familiar with Endoceutics? BIOQuébec: More than 100 Organizations which Boost Quebec’s Economy!

The BIOQuébec network consists of over 100 members of the life sciences industry. Discover more about Endoceutics by viewing its profile!

A Woman to Lead the Génome Québec Board of Directors

A woman will be at the helm of the Génome Québec Board of Directors for the first time since the organization’s inception in 2000. Congratulations to Anie Perrault, LL.L, ASC, for her nomination.

NewsGuest UserMarch 19, 2019BIOOQuébecGénome Québec, Anie Perrault, Board of directors

Review of BIOQuébec’s Recent Political Representations

BIOQuébec actively represents the interests of its members before political authorities. Here is a summary of the actions taken so far in 2019.

Amorchem, A BIOQuébec Member, announces the financing of a new university project

AmorChem Reinforces Its Innate Immunity Franchise with an Investment in Checkpoint Control Target SRSF3.

NewsCatherine LamontagneFebruary 18, 2019BIOOQuébecAmorchem, Univeristé Laval, CERVO

Quebec Regions Fast Forward Challenge, an initiative of the Government of Canada

This opportunity will allow 10 innovative businesses from across Québec to obtain a $50,000 grant to carry out their business projects. Eligible companies can apply between February 8 and April 1, 2019.

Are you Familiar with CTI Life Sciences? BIOQuébec: More than 100 Organizations which Boost Quebec’s Economy!

The BIOQuébec network consists of over 100 members of the life sciences industry. Discover more about CTI Life Sciences by viewing its profile!